Aaron T Seaman1, Kimberly Dukes2, Richard M Hoffman3, Alan J Christensen4, Nicholas Kendell5, Andrew L Sussman6, Miriam Veléz-Bermúdez4, Robert J Volk7, Nitin A Pagedar5. 1. Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, USA. Electronic address: aaron-seaman@uiowa.edu. 2. Institute for Clinical and Translational Science, University of Iowa Hospitals and Clinics, Iowa City, USA. 3. Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, USA. 4. Department of Psychological and Brain Sciences, University of Iowa, Iowa City, USA. 5. Department of Otolaryngology-Head and Neck Surgery, University of Iowa Carver College of Medicine, Iowa City, USA. 6. Family and Community Medicine, University of New Mexico, Albuquerque, USA. 7. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, USA.
Abstract
OBJECTIVE: Shared decision making (SDM) is recommended when offering lung cancer screening (LCS)-which presents challenges with tobacco-related cancer survivors because they were excluded from clinical trials. Our objective was to characterize head and neck cancer (HNC) survivors' knowledge, attitudes, and beliefs toward LCS and SDM. METHODS: Between November 2017 and June 2018, we conducted semi-structured qualitative interviews with 19 HNC survivors, focusing on patients' cancer and smoking history, receptivity to and perceptions of LCS, and decision-making preferences RESULTS: Participants were receptive to LCS, referencing their successful HNC outcomes. They perceived that LCS might reduce uncertainty and emphasized the potential benefits of early diagnosis. Some expressed concern over costs or overdiagnosis, but most minimized potential harms, including false positives and radiation exposure. Participants preferred in-person LCS discussions, often ideally with their cancer specialist. CONCLUSION AND PRACTICE IMPLICATIONS: HNC survivors may have overly optimistic expectations for LCS, and clinicians need to account for this in SDM discussions. Supporting these patients in making informed decisions will be challenging because we lack clinical data on the potential benefits and harms of LCS for cancer survivors. While some patients prefer discussing LCS with their cancer specialists, the ability of specialists to support high-quality decision making is uncertain.
OBJECTIVE: Shared decision making (SDM) is recommended when offering lung cancer screening (LCS)-which presents challenges with tobacco-related cancer survivors because they were excluded from clinical trials. Our objective was to characterize head and neck cancer (HNC) survivors' knowledge, attitudes, and beliefs toward LCS and SDM. METHODS: Between November 2017 and June 2018, we conducted semi-structured qualitative interviews with 19 HNC survivors, focusing on patients' cancer and smoking history, receptivity to and perceptions of LCS, and decision-making preferences RESULTS:Participants were receptive to LCS, referencing their successful HNC outcomes. They perceived that LCS might reduce uncertainty and emphasized the potential benefits of early diagnosis. Some expressed concern over costs or overdiagnosis, but most minimized potential harms, including false positives and radiation exposure. Participants preferred in-person LCS discussions, often ideally with their cancer specialist. CONCLUSION AND PRACTICE IMPLICATIONS: HNC survivors may have overly optimistic expectations for LCS, and clinicians need to account for this in SDM discussions. Supporting these patients in making informed decisions will be challenging because we lack clinical data on the potential benefits and harms of LCS for cancer survivors. While some patients prefer discussing LCS with their cancer specialists, the ability of specialists to support high-quality decision making is uncertain.
Keywords:
Attitudes; Decision making; Early detection of cancer; Head and neck neoplasms; Health knowledge; Lung neoplasms; Practices; Qualitative research; Shared
Authors: Vani N Simmons; Jhanelle E Gray; Matthew B Schabath; Lauren E Wilson; Gwendolyn P Quinn Journal: Lung Cancer Date: 2017-01-31 Impact factor: 5.705
Authors: Sirisha Jonnalagadda; Cara Bergamo; Jenny J Lin; Linda Lurslurchachai; Michael Diefenbach; Cardinale Smith; Judith E Nelson; Juan P Wisnivesky Journal: Lung Cancer Date: 2012-06-06 Impact factor: 5.705
Authors: Kristina Crothers; Erin K Kross; Lisa M Reisch; Shahida Shahrir; Christopher Slatore; Steven B Zeliadt; Matthew Triplette; Rafael Meza; Joann G Elmore Journal: Ann Am Thorac Soc Date: 2016-11
Authors: Neeti M Kanodra; Charlene Pope; Chanita H Halbert; Gerard A Silvestri; LaShanta J Rice; Nichole T Tanner Journal: Ann Am Thorac Soc Date: 2016-11
Authors: Richard M Hoffman; Andrew L Sussman; Christina M Getrich; Robert L Rhyne; Richard E Crowell; Kathryn L Taylor; Ellen J Reifler; Pamela H Wescott; Ambroshia M Murrietta; Ali I Saeed; Shiraz I Mishra Journal: Prev Chronic Dis Date: 2015-07-09 Impact factor: 2.830
Authors: Nitin A Pagedar; Nicholas Kendell; Alan J Christensen; Timothy A Thomsen; Michaela Gist; Aaron T Seaman Journal: Head Neck Date: 2020-05-23 Impact factor: 3.147
Authors: Kimberly Dukes; Aaron T Seaman; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Vélez-Bermúdez; Robert J Volk; Nitin A Pagedar Journal: Ann Otol Rhinol Laryngol Date: 2019-08-13 Impact factor: 1.547